Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K/A - Adverum Biotechnologies, Inc. | d551546d8ka.htm |
Exhibit 16.1
March 22, 2018
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549-7581
Dear Sirs/Madams:
We have read Item 4.01 of Adverum Biotechnologies Inc.’s Form 8-K dated March 22, 2018, and have the following comments:
| 1. | We agree with the statement made in the second to last sentence in paragraph 1 and the statements made in paragraphs 2, 3 and 4. |
| 2. | We have no basis on which to agree or disagree with the remaining statements made in paragraphs 1 and 5. |
Yours truly,
/s/ Deloitte & Touche LLP
San Jose, CA